References

Gut microbiota dysbiosis promotes the development of epithelial ovarian cancer via regulating Hedgehog signaling pathway

10.1080/19490976.2023.2221093 · 2023 · External reference

Polycystic Ovary Syndrome and Endometrial Cancer: A Scoping Review of the Literature on Gut Microbiota

10.3390/cells11193038 · 2022 · External reference

Magnolin targeting of the JNK/Sp1/MMP15 signaling axis suppresses cervical cancer microenvironment and metastasis via microbiota modulation

10.1016/j.canlet.2023.216584 · 2024 · External reference

Microbes in gynecologic cancers: Causes or consequences and therapeutic potential

10.1016/j.semcancer.2021.07.013 · 2022 · External reference

Estrogen gut microbiome axis: Physiological and clinical implications

10.1016/j.maturitas.2017.06.025 · 2017 · External reference

Flavonoids as Anticancer Agents

10.3390/nu12020457 · 2020 · External reference

The gut microbiome and efficacy of cancer immunotherapy

10.1016/j.pharmthera.2021.107973 · 2022 · External reference

The Potential of the Gut Microbiome to Reshape the Cancer Therapy Paradigm

10.1001/jamaoncol.2022.0494 · 2022 · External reference

First-in-class microbial ecosystem therapeutics 4 (MET4) in metastatic solid cancer patients treated with immunotherapy: MET4-IO

10.1200/jco.2020.38.15_suppl.3098 · 2020 · External reference

Immune modulation and the oral live biotherapeutic product, MRx0518, in treatment-naive patients with cancer: Updated safety data

10.1200/jco.2023.41.16_suppl.3145 · 2023 · External reference

Bioinorganic hybrid bacteriophage for modulation of intestinal microbiota to remodel tumor-immune microenvironment against colorectal cancer

10.1126/sciadv.aba1590 · 2020 · External reference